Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion

Use of yttrium-90 (Y-90) is used for primary liver tumors and a handful of liver metastatic lesions. Y-90 treatment for metastatic adrenocortical carcinoma (ACC) to the liver is currently off-label, with one previously documented case report. In this case report, we present a 52-year-old woman with...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Case Reports in Oncology
المؤلفون الرئيسيون: Nicholas Pigg, Daniel Aboubechara, Roberto Fourzali, Brian Baigorri
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Karger Publishers 2020-02-01
الموضوعات:
yttrium-90 radioembolization
adrenocortical carcinoma
hepatic metastases
الوصول للمادة أونلاين:https://www.karger.com/Article/FullText/504779

الانترنت

https://www.karger.com/Article/FullText/504779

مواد مشابهة